Alberta Investment Management Corp (AIMCo)’s Bio-Rad Laboratories Class A BIO Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,200	Closed	-$415K	–	739
2024 Q1	$415K	Buy	+1,200	New	+$395K	﹤0.01%	852
2023 Q4	–	Sell	-600	Closed	-$215K	–	1028
2023 Q3	$215K	Hold	600	–	–	﹤0.01%	967
2023 Q2	$227K	Hold	600	–	–	﹤0.01%	1111
2023 Q1	$287K	Buy	+600	New	+$281K	﹤0.01%	1098
2022 Q4	–	Sell	-2,162	Closed	-$902K	–	1095
2022 Q3	$902K	Hold	2,162	–	–	0.01%	946
2022 Q2	$1.07M	Sell	2,162 -8,324	-79%	-$4.34M	0.01%	866
2022 Q1	$5.91M	Buy	10,486 +6,186	+144%	+$3.73M	0.03%	498
2021 Q4	$3.25M	Hold	4,300	–	–	0.02%	524
2021 Q3	$3.21M	Hold	4,300	–	–	0.03%	531
2021 Q2	$2.77M	Buy	+4,300	New	+$2.62M	0.02%	565
2021 Q1	–	Sell	-3,100	Closed	-$1.81M	–	831
2020 Q4	$1.81M	Buy	+3,100	New	+$1.77M	0.02%	546

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s BIO Position: Q2 2024 in Review

Alberta Investment Management Corp (AIMCo) sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2024, closing a stake of 1,200 shares — an estimated $415K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in BIO in Q4 2020 and held it in 11 quarters. The position peaked at $5.91M in Q1 2022. 439 funds tracked by Wall St. Rank hold BIO as of Q2 2024.

Alberta Investment Management Corp (AIMCo) reported no remaining Bio-Rad Laboratories Class A position as of Q2 2024 after selling out during the quarter.
Alberta Investment Management Corp (AIMCo) sold 1,200 Bio-Rad Laboratories Class A shares in Q2 2024, an estimated $415K.
Alberta Investment Management Corp (AIMCo) first reported a position in Bio-Rad Laboratories Class A in Q4 2020 and held it in 11 quarters.
Alberta Investment Management Corp (AIMCo)'s Bio-Rad Laboratories Class A position peaked at $5.91M in Q1 2022.
439 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2024.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q2 2024, filed 13 Aug 2024.